Therapeutic Advances in Endocrinology and Metabolism : Impact Factor & More
eISSN: 2042-0196pISSN: 2042-0188
Open AccessShare this on:
Key Metrics
CiteScore 
5.3
Impact Factor
< 5
SJR
Q3Endocrinology, Diabetes and Metabolism
SNIP
1.33
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Therapeutic Advances in Endocrinology and Metabolism
Therapeutic Advances in Endocrinology and Metabolism Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Endocrinology and Metabolism ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Therapeutic Advances in Endocrinology and Metabolism
Maternal TPO-Ab status modulates associations between gestational thyroid hormones and neonatal TSH in 10,154 Chinese mother\u2013newborn pairs
- 10 May 2026
- Therapeutic Advances in Endocrinology and Metabolism
Factors potentiating risk of higher lactate level associated with metformin therapy: a cross-sectional study in an ambulatory care setting
- 3 Apr 2026
- Therapeutic Advances in Endocrinology and Metabolism
Parathyroid carcinoma co-occurring with parathyroid adenoma and papillary thyroid carcinoma: a rare case report with comprehensive literature review
- 3 Apr 2026
- Therapeutic Advances in Endocrinology and Metabolism
Type 2 diabetes mellitus as a state of altered drug pharmacokinetic-pharmacodynamic parameters: an update on recent developments and clinical implications
- 2 Apr 2026
- Therapeutic Advances in Endocrinology and Metabolism
Recurrent pituitary apoplexy: experience from a national registry and review of the literature
- 28 Mar 2026
- Therapeutic Advances in Endocrinology and Metabolism
Association of insulin resistance-related indicators with cardiovascular disease and cardiovascular disease mortality in individuals with MASLD: a population-based study
- 28 Mar 2026
- Therapeutic Advances in Endocrinology and Metabolism
Maternal TPO-Ab status modulates associations between gestational thyroid hormones and neonatal TSH in 10,154 Chinese mother\u2013newborn pairs
- 10 May 2026
- Therapeutic Advances in Endocrinology and Metabolism
Factors potentiating risk of higher lactate level associated with metformin therapy: a cross-sectional study in an ambulatory care setting
- 3 Apr 2026
- Therapeutic Advances in Endocrinology and Metabolism
Parathyroid carcinoma co-occurring with parathyroid adenoma and papillary thyroid carcinoma: a rare case report with comprehensive literature review
- 3 Apr 2026
- Therapeutic Advances in Endocrinology and Metabolism
Type 2 diabetes mellitus as a state of altered drug pharmacokinetic-pharmacodynamic parameters: an update on recent developments and clinical implications
- 2 Apr 2026
- Therapeutic Advances in Endocrinology and Metabolism
Recurrent pituitary apoplexy: experience from a national registry and review of the literature
- 28 Mar 2026
- Therapeutic Advances in Endocrinology and Metabolism
Association of insulin resistance-related indicators with cardiovascular disease and cardiovascular disease mortality in individuals with MASLD: a population-based study
- 28 Mar 2026
- Therapeutic Advances in Endocrinology and Metabolism
FAQs on Therapeutic Advances in Endocrinology and Metabolism
How long has Therapeutic Advances in Endocrinology and Metabolism been actively publishing? 
What is the publishing frequency of Therapeutic Advances in Endocrinology and Metabolism?
How many articles did Therapeutic Advances in Endocrinology and Metabolism publish last year?
What is the eISSN & pISSN for Therapeutic Advances in Endocrinology and Metabolism?
What is Citescore for Therapeutic Advances in Endocrinology and Metabolism?
What is SNIP score for Therapeutic Advances in Endocrinology and Metabolism?
What is the SJR for Therapeutic Advances in Endocrinology and Metabolism?
Who is the publisher of Therapeutic Advances in Endocrinology and Metabolism?
